NCT04102449View on ClinicalTrials.gov

Validation of the PsASon ULtrasound Scores in Patients With Psoriatic Arthritis Undergoing TReatment With Apremilast

PHASE4WithdrawnINTERVENTIONAL
0
Timeline

Start Date

July 1, 2020

Primary Completion Date

February 28, 2022

Study Completion Date

February 28, 2022

Conditions
Psoriatic Arthritis
Interventions
DRUG

Apremilast

Single arm receiving Apremilast and ultrasound examinations

Trial Locations (1)

8010

Medical University of Graz, Graz

Sponsors

Collaborators (1)

Celgene Corporation
All Listed Sponsors
collaborator

Celgene Corporation

INDUSTRY

collaborator

Medical University of Vienna

OTHER

collaborator

Medical University Innsbruck

OTHER

lead

Medical University of Graz

OTHER